SBH
UTHR icon

Segall Bryant & Hamill’s United Therapeutics UTHR Stock Holding History

Segall Bryant & Hamill’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,632
Closed -$3.05M – 736
2023
Q1 		$3.05M Buy
13,632
+12
+0.1% +$2.96K 0.03% 395
2022
Q4 		$3.79M Sell
13,620
-4,859
-26% -$1.23M 0.04% 363
2022
Q3 		$3.87M Buy
18,479
+975
+6% +$218K 0.05% 351
2022
Q2 		$4.12M Sell
17,504
-3,992
-19% -$812K 0.05% 350
2022
Q1 		$3.86M Sell
21,496
-2,342
-10% -$446K 0.04% 366
2021
Q4 		$5.15M Buy
23,838
+570
+2% +$112K 0.05% 320
2021
Q3 		$4.3M Buy
23,268
+931
+4% +$183K 0.04% 360
2021
Q2 		$4.01M Buy
+22,337
New +$4.25M 0.04% 366

Other funds holding UTHR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return